J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
about
Blood pressure targets for the treatment of patients with hypertension and cardiovascular diseaseBlood pressure targets for hypertension in people with diabetes mellitusThe J-Curve Phenomenon in HypertensionUnderstanding and treating hypertension in diabetic populationsWhat is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsDifferences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysisPre-hypertension: how low to go and do drugs have a role?Oscillating blood pressure therapeutic target in type 2 diabetes patients with hypertensionFrom hypertension to stroke: mechanisms and potential prevention strategies.Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.Does baseline hypotension predict incident depression in a cohort of community-dwelling older people? Data from The Irish Longitudinal Study on Ageing (TILDA).Redefined blood pressure variability measure and its association with mortality in elderly primary care patientsBP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population.2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.Effect of cocoa on blood pressure.Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevanceTarget blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?The significance of the j-curve in hypertension and coronary artery diseases.Low systolic blood pressure and mortality from all causes and vascular diseases among older middle-aged men: Korean Veterans Health Study.Primary stroke prevention and hypertension treatment: which is the first-line strategy?24-Hour ambulatory blood pressure associates inversely with prostaglandin F(2α), interleukin-6 and F(2)-isoprostane formation in a Swedish population of older men.Initial blood pressure is associated with stroke severity and is predictive of admission cost and one-year outcome in different stroke subtypes: a SRICHS registry study.Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.Low systolic blood pressure and mortality from all-cause and vascular diseases among the rural elderly in Korea; Kangwha cohort studyAssociation of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study.Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial.Blood pressure j-curve: current conceptsThe Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults.Evidence to Maintain the Systolic Blood Pressure Treatment Threshold at 140 mm Hg for Stroke Prevention: The Northern Manhattan StudyLow Diastolic Blood Pressure as a Risk for All-Cause Mortality in VA Patients.Diabetes, hypertension, and outcome studies: overview 2010.Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent RestenosisLongitudinal Patterns of Blood Pressure, Incident Cardiovascular Events, and All-Cause Mortality in Normotensive Diabetic PeopleBlood pressure levels and stroke: J-curve phenomenon?Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.Update on pathophysiology and treatment of hypertension in the elderly.Hypertensive goals in patients with coronary artery disease.Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes.
P2860
Q24201957-3CBC064A-8E59-4960-9881-DF2BEFF5A9D9Q24202854-35F4B225-1D0E-4AA5-BE8F-F824DD8575ECQ26738834-8DD5432C-5935-42A0-B769-5AB086763387Q26778662-EBBE53AC-F205-43F3-8979-14D8CBAE589BQ26864349-28A05F7F-A384-48B6-A6DF-E2EA40E3A524Q27001759-E375EC29-B8EA-46A1-A000-DD1C2EA216DBQ27007552-981C6315-6E37-45B1-B022-5429EAEBCBD8Q28068633-BF6996B2-D6EE-42D6-8351-59D6AC3D7B44Q30407495-7B533BE2-F6BE-445C-8454-4EE10E1BA282Q30410815-75FCBF00-8D16-47DC-9279-693998F87AFCQ33168451-9BA6F8A0-D5A3-42F1-9DE8-5B18F710B6C0Q33754223-4C87BEEA-4005-488A-8BFE-5D28C9755469Q33814858-E64C39D8-8042-438C-B0B3-852487672AB5Q34060319-22AAF8C0-9C2D-41B1-8C64-564A8A144B28Q34321437-7248AB00-ED1E-41D0-8F53-7C6AB3BB7D05Q34681652-A7F8B723-1BE9-4FE4-86B0-5ED920FB9F57Q34700821-20235B3C-6D30-40CC-949E-14633FDFBF38Q35148838-08CCA174-3CBB-4EC1-B19C-A8BB49C1B506Q35154427-D0A800F1-8078-447C-94DC-B40E565DAB43Q35430271-B79A2A21-577C-4BC0-8457-70F7BD49051DQ35513559-B37B3E9B-47DE-4D91-80E1-5EB921F975E7Q35929612-381E2756-2CC7-4A61-85B7-44D61E0F2BDCQ35938766-65480798-720D-4A60-806D-4F4E71BC9334Q36016796-85112C75-C9ED-4CEE-A574-6FF5BBA59D2CQ36069269-A0B34A36-8045-4B15-9176-3B01D5B442C3Q36151505-E532DE52-2FDF-44F7-8D72-D0D611017852Q36200726-B6022F4A-FB8A-4425-99E6-F19FC01E4DA8Q36373385-BF2483F3-2B73-4889-A498-5A4BAC3394E0Q36374410-7CFBC31C-180E-4E00-8A77-960BB409A39DQ36394802-69E050E4-8152-47F1-9E1C-764EA4960592Q36576594-91D69134-BFD4-4403-8E06-01289D039658Q36757972-423624D8-BFB3-4F15-BC06-35877D520BCBQ36783690-AD9E5031-8C8D-439E-96B4-757968C516A3Q36950156-992B0F3D-A429-4369-BDCE-0018184626D8Q37170469-596F77D4-0BA5-4C4F-812C-0D0F13E8104AQ37337561-301620D0-8185-4E09-A879-EED01F3BA546Q37574305-C49A8EC0-6F16-462B-B9EE-3A5FF50A725DQ37890891-6260CC83-303F-4A8F-8572-26F95277D444Q38034474-E7EE3FBD-FE2F-4562-892F-4A739FFF756DQ38055501-6EF8785F-19C3-404A-98FA-1856F1D86CF8
P2860
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
J-curve revisited: An analysis ...... ng to New Targets (TNT) Trial.
@en
J-curve revisited: An analysis ...... in the Treating to New Targets
@nl
type
label
J-curve revisited: An analysis ...... ng to New Targets (TNT) Trial.
@en
J-curve revisited: An analysis ...... in the Treating to New Targets
@nl
prefLabel
J-curve revisited: An analysis ...... ng to New Targets (TNT) Trial.
@en
J-curve revisited: An analysis ...... in the Treating to New Targets
@nl
P2093
P2860
P356
P1476
J-curve revisited: An analysis ...... ng to New Targets (TNT) Trial.
@en
P2093
Andrea L Zuckerman
Chuan-Chuan Wun
David DeMicco
Franz H Messerli
John B Kostis
John C LaRosa
Treating to New Targets Steering Committee and Investigators
P2860
P304
P356
10.1093/EURHEARTJ/EHQ328
P577
2010-09-16T00:00:00Z